Labcorp Holdings Inc. (LON:0JSY)
260.89
+0.41 (0.16%)
At close: Jun 30, 2025
Labcorp Holdings Revenue
Labcorp Holdings had revenue of $3.35B USD in the quarter ending March 31, 2025, with 5.30% growth. This brings the company's revenue in the last twelve months to $13.18B, up 7.13% year-over-year. In the year 2024, Labcorp Holdings had annual revenue of $13.01B with 6.97% growth.
Revenue (ttm)
$13.18B
Revenue Growth
+7.13%
P/S Ratio
1.56
Revenue / Employee
$188.25K
Employees
70,000
Market Cap
15.90B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 13.01B | 847.30M | 6.97% |
Dec 31, 2023 | 12.16B | 297.70M | 2.51% |
Dec 31, 2022 | 11.86B | -1.27B | -9.68% |
Dec 31, 2021 | 13.14B | -842.40M | -6.03% |
Dec 31, 2020 | 13.98B | 2.42B | 20.98% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Labcorp Holdings News
- 16 hours ago - Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low - Seeking Alpha
- 4 days ago - Labcorp to Announce Second Quarter Financial Results on July 24, 2025 - PRNewsWire
- 18 days ago - Insider Decision: Kerrii B Anderson Offloads $130K Worth Of Labcorp Hldgs Stock - Benzinga
- 4 weeks ago - ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage - GlobeNewsWire
- 4 weeks ago - Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research - PRNewsWire
- 6 weeks ago - Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight - Benzinga
- 7 weeks ago - Labcorp to Webcast Its Annual Meeting of Shareholders May 15 - PRNewsWire
- 2 months ago - Labcorp targets 10% EPS growth with new diagnostics and acquisitions strategy - Seeking Alpha